Placeholder

Propranolol

CAS No:
525-66-6 Categories: , ,
  • # LGM Pharma is a Propranolol CAS# 525-66-6 API supplier distributor based in the USA. Inquire about DMF, cGMP, price, availability, samples, sourcing, purity and more.
  • # Questions? Call our customer API support number 1-(800)-881-8210.
  • # LGM Pharma offers this active ingredient but not the finished dosage forms.
  • Inquire about this product >>

Product Details:

  • Product Name: Propranolol
  • CAS #: 525-66-6
  • IUPAC: 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)- (9CI)
  • Formula: C16-H21-N-O2
  • Molecular Mass: 259.347
  • Synonyms: 1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol, 1-Isopropylamino-3-(1-naphthyloxy)-2-propanol, 2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, 2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-, Anapriline, Avlocardyl, AY 20694, AY-20694, beta-Propranolol, Betadren, Betalong, CCRIS 3082, Corpendol, Dociton, EINECS 208-378-0, Euprovasin, Propanix, Propanolol, Propanolol [INN-Spanish], Propranolol, Propranololo, Propranololo [DCIT], Propranololum, Propranololum [INN-Latin], Proprasylyt, Reducor, Sawatal, Sumial, UNII-9Y8NXQ24VQ
  • SMILES: c12c(OC[C@@H](CNC(C)C)O)cccc1cccc2
  • InChl: 1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk.

API’s From Quality Manufacturers:

  • Streamlined API supply towards initial research stages as well as larger quantities of cGMP material for clinical trials and product commercialization
  • Premium quality GMP certified and fully accredited API manufacturing plants

 

  • Technical packages as well as access to filed DMF,
    ASMF or CEP (subject to availability)
  • Regulatory and technical assistance towards any
    submission type based on specific customer requirements
This website uses cookies. By using our site, you agree to our terms of service